Usman Baber to Myocardial Ischemia
This is a "connection" page, showing publications Usman Baber has written about Myocardial Ischemia.
Connection Strength
2.211
-
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a Reappraisal. J Am Coll Cardiol. 2021 07 27; 78(4):362-364.
Score: 0.723
-
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004945.
Score: 0.605
-
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):192-194.
Score: 0.149
-
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):E217-E225.
Score: 0.129
-
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. Am J Cardiol. 2016 Jun 15; 117(12):1877-83.
Score: 0.125
-
Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. Am Heart J. 2015 Dec; 170(6):1234-42.
Score: 0.120
-
Antiplatelet therapy after drug-eluting stent implantation. J Cardiol. 2015 Feb; 65(2):98-104.
Score: 0.113
-
A simple scoring tool for the evaluation of patients in an emergency department chest pain unit. Conn Med. 2014 Sep; 78(8):465-74.
Score: 0.112
-
Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. Am J Cardiol. 2009 Jun 01; 103(11):1513-7.
Score: 0.077
-
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials. Circ Cardiovasc Interv. 2015 Aug; 8(8):e002475.
Score: 0.030
-
Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? Curr Opin Cardiol. 2014 Jul; 29(4):301-6.
Score: 0.028